Why LDSYF stands out from most other cannabis comp
Post# of 60
(Total Views: 910)
Posted On: 11/23/2017 9:45:36 AM
Why LDSYF stands out from most other cannabis companies ? They are in it with high aims and strong partners. They do clinal work/tries in collaboration with clinics and pharma industry.
The first step is the strips and that is very important. This will build a solid base to the pharma side. When they get going with a steady revenue from strips, I think they will expand there clinical studies and in the long run come with other products to market.
Quality Above All Else. The current shortage of cannabis production in California that is capable of passing laboratory testing, a 2018 state requirement in order to sell to dispensaries, is staggering. According to the Los Angeles Times more than 80% of sampled cannabis grown in California was contaminated with pesticides, fungicides and/or infestation. Consequently, the majority of cannabis grown in California would not pass the proposed 2018 safe levels of purity.
The Big Short(age). It now boils down to simply economics. The demand for cannabis in California in 2018 is expected to increase by about 50% from 2017, and the number of properly licensed cannabis growers and sellers will decrease by at least the same percentage. Unlike any other time in California’s history, the State of California will be regulating all things Cannabis. The State of California is notorious for getting what it wants – and starting in 2018 it wants cannabis tax revenue. Lots and lots of tax revenue.
Incredible Opportunity Awaits. It’s anticipated that very few companies will be able to better capitalize on the significant increase in demand and simultaneous decrease in supply than Lifestyle
Delivery Systems Inc. (CSE: LDS, OTCQB: LDSYF). Located in southern California, LDS is a vertically integrated publicly traded company that spent $6 million to retrofit and fully equip a 20,000 sq. ft. facility in the “Green Zone” of Adelanto, CA. Its facility comprises eight isogenic rooms, an agricultural nursery, a cultivation division, three distillation and extraction laboratories, as well as a manufacturing division for CannaStrips™, the company’s sub-lingual dissolvable strips that have various degrees of active ingredients from the medicinal cannabis plant.
The first step is the strips and that is very important. This will build a solid base to the pharma side. When they get going with a steady revenue from strips, I think they will expand there clinical studies and in the long run come with other products to market.
Quality Above All Else. The current shortage of cannabis production in California that is capable of passing laboratory testing, a 2018 state requirement in order to sell to dispensaries, is staggering. According to the Los Angeles Times more than 80% of sampled cannabis grown in California was contaminated with pesticides, fungicides and/or infestation. Consequently, the majority of cannabis grown in California would not pass the proposed 2018 safe levels of purity.
The Big Short(age). It now boils down to simply economics. The demand for cannabis in California in 2018 is expected to increase by about 50% from 2017, and the number of properly licensed cannabis growers and sellers will decrease by at least the same percentage. Unlike any other time in California’s history, the State of California will be regulating all things Cannabis. The State of California is notorious for getting what it wants – and starting in 2018 it wants cannabis tax revenue. Lots and lots of tax revenue.
Incredible Opportunity Awaits. It’s anticipated that very few companies will be able to better capitalize on the significant increase in demand and simultaneous decrease in supply than Lifestyle
Delivery Systems Inc. (CSE: LDS, OTCQB: LDSYF). Located in southern California, LDS is a vertically integrated publicly traded company that spent $6 million to retrofit and fully equip a 20,000 sq. ft. facility in the “Green Zone” of Adelanto, CA. Its facility comprises eight isogenic rooms, an agricultural nursery, a cultivation division, three distillation and extraction laboratories, as well as a manufacturing division for CannaStrips™, the company’s sub-lingual dissolvable strips that have various degrees of active ingredients from the medicinal cannabis plant.
(0)
(0)Core One Labs Inc. (CLABF) Stock Research Links
Robert